| 101301-0 | XR Thoracic spine Views 2 and Abdomen AP and Lateral | RAD |
| 101302-8 | Leptospira sp DNA (Blood, qualitative, naa with non-probe detection) | MICRO |
| 101303-6 | Chikungunya virus RNA (Blood, qualitative, naa with non-probe detection) | MICRO |
| 101304-4 | Dengue virus 1+2+3+4 RNA (Blood, qualitative, naa with non-probe detection) | MICRO |
| 101305-1 | Plasmodium sp DNA (Blood, qualitative, naa with non-probe detection) | MICRO |
| 101306-9 | Plasmodium falciparum DNA (Blood, qualitative, naa with non-probe detection) | MICRO |
| 101307-7 | Plasmodium vivax+ovale DNA (Blood, qualitative, naa with non-probe detection) | MICRO |
| 101308-5 | Glucose post arginine stimulation panel - Serum or Plasma | PANEL.CHAL |
| 101309-3 | Glucose --2 hours post dose arginine | CHAL |
| 10131-1 | T' wave amplitude in lead AVL | EKG.MEAS |
| 101310-1 | Somatotropin post insulin stimulation panel - Serum or Plasma | PANEL.CHAL |
| 101311-9 | 17-Hydroxyprogesterone --30 minutes post dose corticotropin | CHAL |
| 101312-7 | 17-Hydroxyprogesterone --1 hour post dose corticotropin | CHAL |
| 101313-5 | 17-Hydroxyprogesterone post corticotropin stimulation panel - Serum or Plasma | PANEL.CHAL |
| 101314-3 | 17-Hydroxypregnenolone and 17-Hydroxyprogesterone p corticotropin stim panel - Serum or Plasma | PANEL.CHAL |
| 101315-0 | Cortisol and Cortisone panel - Urine | PANEL.CHEM |
| 101316-8 | Cortisol and 17-Hydroxyprogesterone post corticotropin stimulation panel - Serum or Plasma | PANEL.CHAL |
| 101317-6 | 17-Hydroxypregnenolone --30 minutes post dose corticotropin | CHAL |
| 101318-4 | 17-Hydroxypregnenolone --1 hour post dose corticotropin | CHAL |
| 101319-2 | Cortisol and Cortisone panel - 24 hour Urine | PANEL.CHEM |
| 10132-9 | T' wave amplitude in lead AVR | EKG.MEAS |
| 101321-8 | MDS v3.0 - RAI v1.18.11 - Self-Care - Admission Performance | PANEL.SURVEY.CMS |
| 101322-6 | MDS v3.0 - RAI v1.18.11 - Self-Care - Discharge Goal | PANEL.SURVEY.CMS |
| 101323-4 | MDS v3.0 - RAI v1.18.11 - Mobility - Admission Performance during assessment period | PANEL.SURVEY.CMS |
| 101324-2 | MDS v3.0 - RAI v1.18.11 - Mobility - Discharge Goal during assessment period | PANEL.SURVEY.CMS |
| 101325-9 | MDS v3.0 - RAI v1.18.11 - Tub/shower transfer - functional goal (qualitative) | SURVEY.CMS |
| 101326-7 | MDS v3.0 - RAI v1.18.11 - Pain assessment interview during assessment period | PANEL.SURVEY.CMS |
| 101327-5 | MDS v3.0 - RAI v1.18.11 - Nutritional approaches - on admission during assessment period | SURVEY.CMS |
| 101328-3 | MDS v3.0 - RAI v1.18.11 - Nutritional approaches - at discharge during assessment period | SURVEY.CMS |
| 101329-1 | MDS v3.0 - RAI v1.18.11 - Participation in assessment and goal setting | PANEL.SURVEY.CMS |
| 10133-7 | T' wave amplitude in lead I | EKG.MEAS |
| 101330-9 | MDS v3.0 - RAI v1.18.11 - Number of venous and arterial ulcers during assessment period | SURVEY.CMS |
| 101331-7 | MDS v3.0 - RAI v1.18.11 - Ulcers, wounds and skin problems during assessment period | SURVEY.CMS |
| 101332-5 | MDS v3.0 - RAI v1.18.11 - Reason referral to local contact agency not made | SURVEY.CMS |
| 101333-3 | MDS v3.0 - RAI v1.18.11 - Determination of pressure injury risk | SURVEY.CMS |
| 101334-1 | Etizolam/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 101335-8 | Etizolam (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 101336-6 | Wr sup(b) Ag on Red Blood Cells (qualitative) | BLDBK |
| 101337-4 | Treatment preferences under certain health conditions | SURVEY.GNHLTH |
| 101338-2 | Coagulation factor X inhibitor in Platelet poor plasma (chromogenic method) | COAG |
| 101339-0 | Cholesterol in Fibroblast (qualitative, filipin stain) | PATH |
| 10134-5 | T' wave amplitude in lead II | EKG.MEAS |
| 101340-8 | Aeromonas sp DNA (Stool, qualitative, naa with probe detection) | MICRO |
| 101341-6 | BK virus DNA (viral load) (Blood, naa with probe detection) | MICRO |
| 101342-4 | JC virus DNA (viral load) (naa with probe detection) | MICRO |
| 101343-2 | Erythrocytes.parasite sp infected/cells (Blood) | MICRO |
| 101344-0 | Acute febrile illness global pathogens panel - Blood (naa with non-probe detection) | PANEL.MICRO |
| 101345-7 | Candida krusei DNA in Specimen (qualitative, naa with probe detection) | MICRO |
| 101346-5 | MDS v3.0 - RAI v1.18.11 - Special Treatments, Procedures, and Programs | PANEL.SURVEY.CMS |
| 101347-3 | MDS v3.0 - RAI v1.18.11 - Return to community | PANEL.SURVEY.CMS |